Project Launched by VTT Develops Computer Models for Predicting Dietary Effects on Health
- Details
- Category: Research
VTT is launching an extensive EU project called ETHERPATHS, studying the effects of dietary effects mediated by gut microbiota on lipid metabolism. The aim is to accelerate the development of health-promoting foods. The project develops computer assisted models with which food companies and research institutions, for instance, will be able to predict the effects of foods in the body.
The Five Myths of Generic Competition
- Details
- Category: Research
The Healthcare and Science business of Thomson Reuters has released the white paper, "The Five Myths of Generic Competition," highlighting what originator pharmaceutical and biotech companies can do to improve their forecasting of the likely timing, source and intensity of competition from generic drugs.
New communication opportunities for providers of medical scientific information
- Details
- Category: Research
Deutsche Zeitschrift für Klinische Forschung (DZKF) portal, developed by Geelen & Geelen Beratung für medizinisch-wissenschaftliche Projekte GmbH, now is available in English. The portal is password protected
and accessible only by medical scientific professionals, it allows to publish and read multimedia-format information and send others the related web link(s).
Three Ways for Pharma Product Sites to Improve Visitor Satisfaction and Retain Consumers
- Details
- Category: Research
![Manhattan Research Manhattan Research](http://www.worldpharmanews.com/images/stories/logo/manhattanresearch.gif)
U.S. Adults With Diabetes Take Control of Care Through Innovative Use of Digital Resources
- Details
- Category: Research
![Manhattan Research Manhattan Research](http://www.worldpharmanews.com/images/stories/logo/manhattanresearch.gif)
Biopharmaceutical Companies Risk Delays in Producing Targeted Treatment Solutions
- Details
- Category: Research
A new survey released by IBM (NYSE: IBM) and Silico Research reveals that if biopharmaceutical - or life-sciences - companies fail to collaborate, they risk costly delays in the production of new medicines, medical devices, diagnostics and support services.
Heart attacks linked with antiretroviral treatment
- Details
- Category: Research
New research has helped to explain why patients being treated with antiretroviral drugs for HIV experience a greater incidence of heart attacks. The research was presented by doctors and researchers from the School of Medicine and Medical Sciences at University College Dublin, the Mater Misericordiae University Hospital in Dublin and the Royal College of Surgeons in Ireland at the Retroviral Conference in Montreal, Canada, on 11 February.
More Pharma News ...
- Study highlights tragedy of avoidable adverse drug reactions
- Key Demographics and Behaviors for Consumers Using Search Engines for Online Health and Pharma Info
- The Future of Mobile Health: Mobile Adoption, mHealth and Mobile Marketing
- Manhattan Research Releases Top Pharma Brand Product Sites by Consumer Satisfaction
- Magnetic Resonance Imaging to Assess the Effect of Therapy
- Taking the Pulse® Asia Gives Insight to How Physicians Use Technology
- Med-ePHV Project Keeping an Eye on Medicine